Lucila Garcia-Contreras, Ph.D.

Assistant Professor

Department of Pharmaceutical Sciences

Phone (405) 271-6593 x47205

Fax (405) 271-7505

Office CPB 321

Email lucila-garcia-contreras@ouhsc.edu


Education & Experience

Master of Science in Science

Dept. of Pharmaceutics, College of Pharmacy, Univ. of Georgia, Athens, GA.

1995

Doctor of Philosophy, in Philosophy

College of Pharmacy, Univ. of Georgia, Dept. of Pharmaceutical and Biomedical Sciences, , Athens, GA

1999

Postdoctoral Fellowship in Division of Drug Delivery and Disposition

School of Pharmacy. Univ. of North Carolina, Chapel Hill, NC

2003


Publications & Presentations

1 2 3 4 > >>
  • Mahjabeen S, Hatipoglu M K, Chandra V, Benbrook D M, Garcia-Contreras L. Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia. Journal of pharmaceutical sciences. 2018; 107 : 638-646
  • Benbrook D M, Janakiram N B, Chandra V, Pathuri G, Madka V, Stratton N C, Masamha C P, Farnsworth C N, Garcia-Contreras L, Hatipoglu M K, Lighfoot S, Rao C V. Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Investigational new drugs. 2017
  • Hatipoglu S M, Mahjabeen S, Garcia-Contreras L. “Pharmacokinetics of inhalable microparticulate SHetA2 nanocrystals for lung cancer treatment”. American Association of Pharmaceutical Scientists (AAPS). 2017
  • Mahjabeen S, Hatipoglu S M, Kosanke S D, Benbrook D M, Garcia-Contreras L. “Influence of Estrous Cycle on the absorption of SHetA2 from Vaginal Suppositories to Treat Cervical Dysplasia”. American Association of Pharmaceutical Scientists (AAPS). 2017
  • Hatipoglu S M, Mahjabeen S, Garcia-Contreras L. “Inhalable Microparticulate SHetA2 Nanocrystals for Lung Cancer Treatment”. OCRID. 2017
  • 1 2 3 4 > >>